C

Concert Pharmaceuticals Inc
F:73C

Watchlist Manager
Concert Pharmaceuticals Inc
F:73C
Watchlist
Price: 7.818 EUR
Market Cap: 374.8m EUR

Wall Street
Price Targets

73C Price Targets Summary
Concert Pharmaceuticals Inc

There are no price targets for 73C.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Concert Pharmaceuticals Inc Competitors:
Price Targets
300685
Amoy Diagnostics Co Ltd
44% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
36% Upside
SERA
Sera Prognostics Inc
76% Upside
CCCC
C4 Therapeutics Inc
480% Upside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
36% Upside
688105
Nanjing Vazyme Biotech Co Ltd
43% Upside
ZEAL
Zealand Pharma A/S
60% Upside
2480
Beijing Luzhu Biotechnology Co Ltd
34% Upside

Revenue
Forecast

Revenue Estimate
Concert Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Concert Pharmaceuticals Inc's revenue is 3%. The projected CAGR for the next 1 year is -89%.

3%
Past Growth
-89%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Concert Pharmaceuticals Inc

Operating Income forecast
is not available for
Concert Pharmaceuticals Inc

Net Income
Forecast

Net Income Estimate
Concert Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 73C's stock price target?
Not Available

73C doesn't have any price targets made by Wall Street professionals.

What is Concert Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
-89%

For the last 8 years the compound annual growth rate for Concert Pharmaceuticals Inc's revenue is 3%. The projected CAGR for the next 1 year is -89%.

Back to Top